Evidence map›Paper›PMID 40212168›Full record

ReviewAnnals of medicine and surgery (2012)2025

Advancements in high-intensity focused ultrasound for urological tumor research and application.

Jun Liu, You-Gang Feng, Cai Zhang, Wen-Zhi Chen

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jun LiuDepartment of Urology, Suining Central Hospital, Suining 629000, China.
You-Gang FengDepartment of Urology, Suining Central Hospital, Suining 629000, China.
Cai ZhangState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing Key Laboratory of Biomedical Engineering, Chongqing 400016, China.
Wen-Zhi ChenState Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing Key Laboratory of Biomedical Engineering, Chongqing 400016, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-intensity focused ultrasound (HIFU), a non-invasive therapeutic approach, has made significant inroads in urological oncology, notably for kidney, bladder, and prostate cancers. Its advantages in treating prostate cancer are particularly pronounced, offering less invasive treatment with faster recovery and superior organ function preservation compared to traditional methods. HIFU is an advantageous option for patients with localized prostate cancer who prefer nonsurgical treatments or have a high demand for quality of life. Despite its benefits, HIFU faces limitations requiring further research and clinical validation to ensure safety and effectiveness. This paper provides a concise review of HIFU's current application in urological tumor treatment, highlighting its role in prostate cancer therapy and exploring its potential in the adjuvant treatment of advanced prostate cancer, offering insights for its future role in urological oncology.

Indexed as

HIFUHigh-intensity focused ultrasoundprostate cancerurological tumors

Identifiers

PMID40212168
PMCPMC11981266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.